Education
About Us
Working with TipRanks
Follow Us
Itonis Inc (ITNS)
OTHER OTC:ITNS
ITNS Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
ITNS FAQ
What was Itonis Inc’s price range in the past 12 months?
Currently, no data Available
What is Itonis Inc’s market cap?
Itonis Inc’s market cap is $914.05K.
When is Itonis Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Itonis Inc’s earnings last quarter?
Currently, no data Available
Is Itonis Inc overvalued?
According to Wall Street analysts Itonis Inc’s price is currently Overvalued.
Does Itonis Inc pay dividends?
Itonis Inc does not currently pay dividends.
What is Itonis Inc’s EPS estimate?
Itonis Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Itonis Inc have?
Itonis Inc has 1,523,409,800 shares outstanding.
What happened to Itonis Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Itonis Inc?
Currently, no hedge funds are holding shares in ITNS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Itonis Inc
Itonis, Inc., a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to alleviate mild to moderate nausea. It has placed a manufacturing order for the first batch of its Emesyl product line. The company was formerly known as Kenshou, Inc. and changed its name to Itonis, Inc. in December 2005. Itonis, Inc. was founded in 2005 and is headquartered in Laguna Hills, California.
Scinai Immunotherapeutics
―
Aditxt
―
PainReform
―
Dermata Therapeutics
―
Conduit Pharmaceuticals
―
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---